Search research articles
Contact Us
Filters
Showing results (1-10 of 27) with videos related to
Page
of 3
Sort By:
Journal of Medical Economics
|
June 2, 2020
Estimating health state utilities associated with a rare disease: familial chylomicronemia syndrome (FCS)
Louis S Matza, Glenn A Phillips, Timothy A Howell, et al.
JAMA Network Open
|
February 6, 2026
Drug Prices, Rebates, and Health Plan Coverage Restrictions
Molly T Beinfeld, Fariel LaMountain, Glenn A Phillips, et al.
Patient Preference and Adherence
|
August 10, 2010
Antipsychotic adherence, switching, and health care service utilization among Medicaid recipients with schizophrenia
Douglas L Noordsy, Glenn A Phillips, Daniel E Ball, et al.
Administration and Policy in Mental Health
|
April 8, 2009
Development of the burden of prior authorization of psychotherapeutics (BoPAP) scale to assess the effects of prior authorization among Texas Medicaid providers
Carolyn M Brown, Esmond Nwokeji, Karen L Rascati, et al.
Muscle & Nerve
|
January 6, 2022
Utilization of MG-ADL in myasthenia gravis clinical research and care
Srikanth Muppidi, Nicholas J Silvestri, Robin Tan, et al.
Journal of Medical Engineering & Technology
|
April 11, 2017
Validation of an ambient measurement system (AMS) for walking speed
Jonathan S Varsanik, Zebadiah M Kimmel, Carl de Moor, et al.
The Journal of Clinical Psychiatry
|
October 5, 2006
The relationship between quality of life and clinical efficacy from a randomized trial comparing olanzapine and ziprasidone
Glenn A Phillips, David L Van Brunt, Suraja M Roychowdhury, et al.
Journal of Affective Disorders
|
August 9, 2011
Development and validation of a patient-report measure of fatigue associated with depression
Louis S Matza, Glenn A Phillips, Dennis A Revicki, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
April 18, 2014
Responder definition of the Multiple Sclerosis Impact Scale physical impact subscale for patients with physical worsening
Glenn A Phillips, Kathleen W Wyrwich, Shien Guo, et al.
Administration and Policy in Mental Health
|
December 8, 2007
Effects of a psychotherapeutic drug prior authorization (PA) requirement on patients and providers: a providers' perspective
Carolyn M Brown, Kristin Richards, Karen L Rascati, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 27) with videos related to
Sort By:
Page
of 3
Journal of Medical Economics
|
June 2, 2020
Estimating health state utilities associated with a rare disease: familial chylomicronemia syndrome (FCS)
Louis S Matza, Glenn A Phillips, Timothy A Howell, et al.
JAMA Network Open
|
February 6, 2026
Drug Prices, Rebates, and Health Plan Coverage Restrictions
Molly T Beinfeld, Fariel LaMountain, Glenn A Phillips, et al.
Patient Preference and Adherence
|
August 10, 2010
Antipsychotic adherence, switching, and health care service utilization among Medicaid recipients with schizophrenia
Douglas L Noordsy, Glenn A Phillips, Daniel E Ball, et al.
Administration and Policy in Mental Health
|
April 8, 2009
Development of the burden of prior authorization of psychotherapeutics (BoPAP) scale to assess the effects of prior authorization among Texas Medicaid providers
Carolyn M Brown, Esmond Nwokeji, Karen L Rascati, et al.
Muscle & Nerve
|
January 6, 2022
Utilization of MG-ADL in myasthenia gravis clinical research and care
Srikanth Muppidi, Nicholas J Silvestri, Robin Tan, et al.
Journal of Medical Engineering & Technology
|
April 11, 2017
Validation of an ambient measurement system (AMS) for walking speed
Jonathan S Varsanik, Zebadiah M Kimmel, Carl de Moor, et al.
The Journal of Clinical Psychiatry
|
October 5, 2006
The relationship between quality of life and clinical efficacy from a randomized trial comparing olanzapine and ziprasidone
Glenn A Phillips, David L Van Brunt, Suraja M Roychowdhury, et al.
Journal of Affective Disorders
|
August 9, 2011
Development and validation of a patient-report measure of fatigue associated with depression
Louis S Matza, Glenn A Phillips, Dennis A Revicki, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
April 18, 2014
Responder definition of the Multiple Sclerosis Impact Scale physical impact subscale for patients with physical worsening
Glenn A Phillips, Kathleen W Wyrwich, Shien Guo, et al.
Administration and Policy in Mental Health
|
December 8, 2007
Effects of a psychotherapeutic drug prior authorization (PA) requirement on patients and providers: a providers' perspective
Carolyn M Brown, Kristin Richards, Karen L Rascati, et al.
Page
of 3